U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1496C>G (p.Ser499Cys) AND Hypercholesterolemia, familial, 1

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Feb 23, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004006466.3

Allele description [Variation Report for NM_000527.5(LDLR):c.1496C>G (p.Ser499Cys)]

NM_000527.5(LDLR):c.1496C>G (p.Ser499Cys)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1496C>G (p.Ser499Cys)
Other names:
NM_000527.5(LDLR):c.1496C>G; p.Ser499Cys
HGVS:
  • NC_000019.10:g.11113672C>G
  • NG_009060.1:g.29292C>G
  • NM_000527.5:c.1496C>GMANE SELECT
  • NM_001195798.2:c.1496C>G
  • NM_001195799.2:c.1373C>G
  • NM_001195800.2:c.992C>G
  • NM_001195803.2:c.1115C>G
  • NP_000518.1:p.Ser499Cys
  • NP_001182727.1:p.Ser499Cys
  • NP_001182728.1:p.Ser458Cys
  • NP_001182729.1:p.Ser331Cys
  • NP_001182732.1:p.Ser372Cys
  • LRG_274t1:c.1496C>G
  • LRG_274:g.29292C>G
  • NC_000019.9:g.11224348C>G
  • NC_000019.9:g.11224348C>G
  • NM_000527.4:c.1496C>G
Protein change:
S331C
Links:
dbSNP: rs766929574
NCBI 1000 Genomes Browser:
rs766929574
Molecular consequence:
  • NM_000527.5:c.1496C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1496C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1373C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.992C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.1115C>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004822464All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Nov 2, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005375307ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel
reviewed by expert panel

(ClinGen FH ACMG Specifications v1-2)
Uncertain Significance
(Feb 23, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided108544not providedclinical testing, curation

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From All of Us Research Program, National Institutes of Health, SCV004822464.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

This missense variant replaces serine with cysteine at codon 499 of the LDLR protein. This variant is also known as p.Ser478Cys in the mature protein. This variant alters a conserved serine residue in the LDLR type B repeat 3 of the EGF precursor homology domain in the LDLR protein (a.a. 486 - 528), where pathogenic missense variants are found enriched (ClinVar-LDLR). Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with familial hypercholesterolemia (Color internal data). This variant has been identified in 3/251458 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Ser499Pro, is reported to cause disease (ClinVar variation ID: 251870), indicating that serine at this position is important for LDLR protein function. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided1not providednot providednot provided

From ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel, SCV005375307.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_000527.5(LDLR):c.1496C>G (p.Ser499Cys) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2 and PP3 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 February 2024. The supporting evidence is as follows: PM2: PopMax MAF = 0.00003764 (0.004%) in European (Finnish) exomes (gnomAD v4.0.0). PP3: REVEL = 0.811.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024